Data / Research funding / Montana / Dermaxon, LLC
Dermaxon, LLC: 3 NIH awards ($884.5K), fiscal years 2021 to 2026
Dermaxon, LLC in Missoula, MT is funded under 3 NIH awards ($884.5K) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- R33ESK4L9GG3
- State
- Montana
Awards
3 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|
| Novel therapeutic target to combat cutaneous lupus | NIH | National Center for Advancing Translational Sciences | 2021 | $298,132 | April 1, 2021 | March 31, 2023 | ASTRUC DIAZ, FANNY | reporter.nih.gov |
| Selective CYP26 inhibitors for the oral treatment of recalcitrant nodular acne. | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 | $295,423 | September 20, 2023 | August 31, 2025 | DIAZ, PHILIPPE J | reporter.nih.gov |
| Targeting retinoid acid metabolic pathways to treat noise-induced hearing loss | NIH | National Institute on Deafness and Other Communication Disorders | 2024 | $290,920 | June 1, 2024 | May 31, 2025 | DIAZ, PHILIPPE J | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|
| 2024 | 1 | $290,920 | 0 | $0 |
| 2023 | 1 | $295,423 | 0 | $0 |
| 2021 | 1 | $298,132 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|
| Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required) | PAR-24-279 | NIH | 93.846 | November 2, 2026 | Not listed | Same assistance listing 93.846 as 1 award here |
| Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed) | PAR-24-280 | NIH | 93.846 | November 2, 2026 | Not listed | Same assistance listing 93.846 as 1 award here |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | PAR-25-370 | NIH | 93.173 | November 16, 2026 | $50,000 | Same assistance listing 93.173 as 1 award here |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-25-369 | NIH | 93.173 | November 18, 2026 | Not listed | Same assistance listing 93.173 as 1 award here |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-25-371 | NIH | 93.173 | November 18, 2026 | Not listed | Same assistance listing 93.173 as 1 award here |
| HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional) | RFA-AT-25-003 | NIH | 93.846 | November 23, 2026 | $375,000 | Same assistance listing 93.846 as 1 award here |
| Restoring Joint Health and Function to Reduce Pain (RE-JOIN) 2.0 | RFA-AR-26-006 | NIH | 93.846 | December 1, 2026 | Not listed | Same assistance listing 93.846 as 1 award here |
| Emerging Global Leader Award (K43 Independent Clinical Trial Required) | PAR-24-295 | NIH | 93.173 | December 3, 2026 | Not listed | Same assistance listing 93.173 as 1 award here |
| Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) | PAR-24-296 | NIH | 93.173 | December 3, 2026 | Not listed | Same assistance listing 93.173 as 1 award here |
| NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed) | RFA-OD-24-011 | NIH | 93.846 | December 4, 2026 | Not listed | Same assistance listing 93.846 as 1 award here |
| Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 Clinical Trial Optional) | PAR-27-039 | NIH | 93.846 | January 5, 2027 | Not listed | Same assistance listing 93.846 as 1 award here |
| Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 Clinical Trial Optional) | PAR-27-040 | NIH | 93.846 | January 5, 2027 | Not listed | Same assistance listing 93.846 as 1 award here |
| Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required) | PAR-24-214 | NIH | 93.173 | January 7, 2027 | $375,000 | Same assistance listing 93.173 as 1 award here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.846 | January 7, 2027 | Not listed | Same assistance listing 93.846 as 1 award here |
| HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed) | RFA-NS-25-023 | NIH | 93.846 | January 15, 2027 | $350,000 | Same assistance listing 93.846 as 1 award here |
| Research Resource for a National Swine Resource and Research Center (U42 Clinical Trial Not Allowed) | PAR-27-029 | NIH | 93.351 | January 25, 2027 | $1 million | Same assistance listing 93.351 as 1 award here |
| National Biomedical Research Centers (P50 Clinical Trial Optional) | PAR-28-017 | NIH | 93.351 | January 25, 2027 | $11.4 million | Same assistance listing 93.351 as 1 award here |
| Integrated Specific Pathogen Free Research Models and Human New Approach Methodologies to Advance HIV/AIDS Research (U42 Clinical Trial Not Allowed) | PAR-28-019 | NIH | 93.351 | January 25, 2027 | $2.7 million | Same assistance listing 93.351 as 1 award here |
| Biomedical Research Environment and Sponsored Programs Administration Development (BRE-SPAD) Program (UC2- Clinical Trial Not Allowed) | PAR-24-268 | NIH | 93.846 | January 27, 2027 | $500,000 | Same assistance listing 93.846 as 1 award here |
| BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS (R18 - Clinical Trial Not Allowed) | RFA-NS-24-031 | NIH | 93.173 | January 28, 2027 | $750,000 | Same assistance listing 93.173 as 1 award here |
Topics of its NIH awards
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.